Biologics in the management of ulcerative colitis - comparative safety and efficacy of TNF-α antagonists
about
Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological TreatmentsDose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World DataEmerging Treatment Options in Mild to Moderate Ulcerative Colitis.Second-generation Flagellin-rPAc Fusion Protein, KFD2-rPAc, Shows High Protective Efficacy against Dental Caries with Low Potential Side Effects.Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management.
P2860
Biologics in the management of ulcerative colitis - comparative safety and efficacy of TNF-α antagonists
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Biologics in the management of ...... efficacy of TNF-α antagonists
@ast
Biologics in the management of ...... efficacy of TNF-α antagonists
@en
Biologics in the management of ...... efficacy of TNF-α antagonists
@nl
type
label
Biologics in the management of ...... efficacy of TNF-α antagonists
@ast
Biologics in the management of ...... efficacy of TNF-α antagonists
@en
Biologics in the management of ...... efficacy of TNF-α antagonists
@nl
prefLabel
Biologics in the management of ...... efficacy of TNF-α antagonists
@ast
Biologics in the management of ...... efficacy of TNF-α antagonists
@en
Biologics in the management of ...... efficacy of TNF-α antagonists
@nl
P2860
P356
P1476
Biologics in the management of ...... efficacy of TNF-α antagonists
@en
P2093
Anita Afzali
Rebecca Fausel
P2860
P356
10.2147/TCRM.S55506
P407
P577
2015-01-01T00:00:00Z